Carbohydrate restriction favorably alters lipoprotein metabolism in Emirati subjects classified with the metabolic syndrome

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 10, 2010, Pages 720-726

  Al Sarraj, T ^a   Saadi, H ^a   Volek, J S ^b   Fernandez, M L ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Apolipoproteins; Carbohydrate restriction; Lipoprotein subfractions; Metabolic syndrome; United Arab Emirates

Indexed keywords

APOLIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BODY COMPOSITION; BODY WEIGHT; CARBOHYDRATE DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTERVENTION STUDY; LOW CARBOHYDRATE DIET; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; UNITED ARAB EMIRATES;

ADOLESCENT; ADULT; APOLIPOPROTEINS; BODY COMPOSITION; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, CARBOHYDRATE-RESTRICTED; DIETARY CARBOHYDRATES; FEMALE; HUMANS; INTERVENTION STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TRIGLYCERIDES; UNITED ARAB EMIRATES; YOUNG ADULT;

EID: 78649737311     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.06.004     Document Type: Article

References (30)

1. Malik M., Razig S.A. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey. Metab Syndr Relat Disord 2008, 6:177-186.
2. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E.T, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716.
3. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002, 106:3143-3421.
4. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
5. Berneis K.K., Krauss R.M. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002, 43:1363-1379.
6. Grundy S.M. Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target. Arch Intern Med 2001, 161:1379-1380.
7. Krauss R.M. Atherogenicity of triglyceride-rich lipoproteins. Am J Cardiol 1998, 81:13B-17B.
8. Zambon A., Bertocco S., Virtturi N., Polentarutti V., Vianello D., Crepaldi G. Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins. Biochem Soc Trans 2003, 31:1070-1074.
9. Rashid S., Watanabe T., Sakaue T., Lewis G.F. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Clin Biochem 2003, 36:421-429.
10. Salonen J.T., Salonen R., Seppanen K., Rauramaa R., Tuomilehto J. HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation 1991, 84:129-139.
11. Lamarche B., Moorjani S., Cantin B., Dagenais G.R., Lupien P.J., Despres J.P. Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men: prospective results from the Quebec cardiovascular study. Arterioscler Thromb Vasc Biol 1997, 17:1098-1105.
12. Johansson J., Carlson L.A., Landou C., Hamsten A. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 1991, 11:174-182.
13. Fernandez M.L., Webb D. The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. The impact of dietary cholesterol. J Am Coll Nutr 2008, 27:1-5.
14. Marcovina S., Packard C.J. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med 2006, 259:437-446.
15. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarctin in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
16. Lamarche B., Moorjani S., Lupien P.J., Cantin B., Bernard P., Dagenais G., et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 1996, 94:273-278.
17. Volek J.S., Sharman M.J., Forsythe C.E. Modification of lipoproteins by very low-carbohydrate diets. J Nutr 2005, 135(6):1339-1342.
18. Krauss R.M. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol 2005, 25:2265-2272.
19. Wood R.J., Volek J.S., Liu Y., Shachter N.S., Contois J.H., Fernandez M.L. Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL and HDL subfraction distribution and size in overweight men. J Nutr 2006, 136:384-389.
20. 2. Clin Chem 1983, 29:2026.
21. Liu M.Y., Xydakis A.M., Hoogeveen R.C., Jones P.H., Smith E.O., Nelson K.W., et al. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem 2005, 51:1102-1109.
22. Mutungi G, Waters D, Ratliff J, Puglisi MJ, Clark RM, Volek JS, et al. Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate restricted diet. J Nutr Biochem 2009. [Epub ahead of print].
23. Foster G.D., Wyatt H.R., Hill J.O., McGuckin B.G., Brill C., Mohammed B.S., et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003, 348:2082-2090.
24. Lewis G.F., Carpentier A., Adeli K., Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002, 23(2):201-229.
25. Le K.A., Tappy L. Metabolic effects of fructose. Curr Opin Nutr Metab Care 2006, 9(4):469-475.
26. Sharman M.J., Gomez A.L., Kraemer W.J., Volek J.S. Very low-carbohydrate and low-fat diets affect fasting lipids and postprandial lipemia differently in overweight men. J Nutr 2004, 134:880-885.
27. Kasim-Karakas S.E., Lane E., Almario R., Mueller W., Walzem R. Effects of dietary fat restriction on particle size of plasma lipoproteins in postmenopausal women. Metabolism 1997, 46(4):431-436.
28. Wai T.W.K., Watts G.F., Barrett P.H.R., Rye K.A., Chan D.C. Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care 2007, 30:2945-2950.
29. Tailleux A., Duriez P., Fruchart J.C., Clavey V. Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis 2002, 164:1-3.
30. Jahn C.E., Osborne J.C., Schaefer E.J., Brewer H.B. In vitro activation of the enzymic activity of hepatic lipase by apo A-II. FEBS Lett 1981, 131:366-368.